PATENT CLAIM ANALYSIS

Application Number: 16037001
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["705", "051000"]

Abstract:
Provided herein are novel and selective high affinity α3β4 nicotinic acetycholine receptor ligands and pharmaceutical compositions thereof. In other embodiments, provided herein are methods of treatment, prevention, or amelioration of a variety of medical disorders such as, for example, drug addiction or pain using the compounds and compositions disclosed herein. In still other embodiments, provided herein are methods of selectively antagonizing receptors such as, for example, the α3β4 nicotinic acetycholine receptor using the compounds and compositions disclosed herein.

Claim (Index 16):
The method of  claim 1 , wherein R 1  is methyl, Y is \u2014NH\u2014 and Xis 2-pyridyl or 2-pyridyl substituted at the 5 position with \u2014Br or \u2014NO 2 .

Metadata:
- Claim Count in Document: 50.0
- Percentile: 95.0
- Lexical Diversity: 1.89362
- Patent Class: 705.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14601194', '15494505', '13004801', '13159497', '14068774']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.1401200815171797
- 35 USC 102 Novelty (BERT): 0.5985794992899889
- Combined Prediction Score: 0.1859660232944606
- Mean Citation Score: 426.712136
- Max Citation Score: 511.1407
- Similarity Product: 473.3148253272652

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test